PEACE in a scientific comparison
Janet Fason, Jeffrey Gudin and Peter Hurwitz published their STRAVA analysis on 24 September 2025. Sixty-five adults used PEACE and 37 a sham patch. This prospective, single-blind case-control comparison collected self-reports at baseline and after 7 and 14 days; the article does not describe random allocation. [1]
Positive changes in everyday wellbeing
In the PEACE group, the mean Perceived Stress Scale (PSS) score fell from 21.05 to 13.95, around one-third less reported stress. The SF-20 mental health domain also improved; the control group's score remained almost unchanged. The table shows group averages, not placebo-adjusted effects or guarantees of individual success. [1]
| Measure | Baseline | After 14 days |
|---|---|---|
| PEACE · PSS (0–40) | 21.05 | 13.95 |
| PEACE · SF-20 mental health (%) | 64.2 | 79.5 |
| Control · SF-20 mental health (%) | 75.9 | 75.7 |
Putting the findings in context
The findings are promising. However, follow-up lasted only 14 days, the groups were unequal in size and differed in average age. Only completed participation was analysed. Additional activities such as exercise and yoga could contribute. Super Patch Company/Srysty Holding Co. funded the study. No side effects were reported during the study; this does not establish universal freedom from side effects. [1]
The preliminary report from 2024
The earlier STRAVA publication reports on the same active group of 65 people. The 2025 article adds a control comparison. We treat these as related reports, not two independent confirmations. [1] [2]
What the current registry shows
As of 13 October 2026, NCT06708715 is registered as active, not recruiting, with 150 participants planned and randomised parallel allocation. No results are posted in the registry. The registered plan and published case-control comparison give different designs and participant numbers; they are presented separately. [3]